Caprion Pharmaceuticals Announces New Biomarker Discovery Collaboration With Vertex Pharmaceuticals Incorporated

MONTREAL--(BUSINESS WIRE)--March 29, 2006--Caprion Pharmaceuticals Inc.'s Applied BioMedicine group today announced a research collaboration with Vertex Pharmaceuticals Incorporated. The collaboration will use Caprion's CellCarta(R) proteomics platform to support clinical biomarker discovery. Caprion will identify potential pharmacodynamic biomarkers in samples from certain clinical and pre-clinical studies conducted by Vertex.